cro.directory
← Compare landing

Innovate Research vs YPrime

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/innovate-research/yprime

CategoryInnovate ResearchYPrime
Listed sitecrocro
SummaryIndian CRO providing end-to-end clinical trial services (Phase I–IV), regulatory support, medical writing, biostatistics, data management, and biospecimen procurement across pharmaceuticals, biologics, medical devices, and nutraceuticals.YPrime delivers configurable eCOA, IRT, and eConsent clinical trial technology platforms with consulting services, supporting ~1,000 studies globally across 19+ therapeutic areas.
Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Clinical Trial Services
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Medical Writing
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Clinical Operations
  • Clinical Trial Services
  • Medical Writing
  • Regulatory Affairs
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
Modalities
  • Small Molecule
  • Biologics (Other)
  • Vaccine
Data not yet provided.
IndicationsData not yet provided.
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Infectious Disease
  • Rare Disease
  • Ophthalmology
Locations
  • Headquarters, Noida, Uttar Pradesh, India
  • Chapel Hill, Chapel Hill, North Carolina, USA
  • Dubai, Dubai, United Arab Emirates
  • Budapest, Budapest, Hungary
  • Weybridge, Weybridge, Surrey, United Kingdom
Data not yet provided.
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.